QNRX

Conviction 0HealthcareScan · Thu, Jun 25, 2026

QNRX$4.21+9.92%

ResistanceSupportVol 14

Vol MA14 929.86K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Quoin Pharmaceuticals, Ltd.PHARMACEUTICAL PREPARATIONSwww.quoinpharma.com ↗

Price4.21

Change+9.92%

Gap-2.87%

Rel volume0.60×

Avg volume662.45K

Avg $ vol2.46M

SMA 204.51

SMA 505.30

SMA 2009.32

Price vs 50-20.56%

Price vs 200-54.85%

MA stackbearish

50/200 cross—

Supertrenddown · 5.91

RSI (14)44

MACD hist-0.02

MACD crossbear · 2d

Stoch %K / %D51 / 27

ADX (14)34

+DI / −DI7 / 23

RSI divergenceBullish

MACD divergenceBullish

ATR %+15.64%

ADR %14.00%

52w high22.30

52w low0.0000

From 52w high-81.12%

Above 52w low—

New 52w highNo

SqueezeOn · 8d

Bollinger width36.87%

%B0.32

Donchian pos50.53%

Donchian high5.15

Donchian low3.25

AVWAP (52w high)12.94

vs AVWAP high-67.46%

AVWAP (52w low)12.73

vs AVWAP low-66.94%

OBV trendUp

Chaikin MF (20)-0.72

Today vs 20d0.60×

Avg vol (14d)929.86K

Avg vol (20d)662.45K

Avg $ vol (20d)2.46M

Market cap14.12B

RS 3m (vs SPY)-64.38%

RS 6m (vs SPY)-80.76%

RS line new highNo

Trend template0/8

Technical rank7.4

1 week-8.87%

1 month-13.02%

3 months-54.58%

6 months-69.38%

1 year-53.12%

YTD-70.10%

P/E-893.60

P/B1609.81

P/S—

P/FCF—

EPS—

Div yield—

ROE-180.15%

ROA-100.71%

Debt/Eq—

Current2.87

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-76.34%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value14.12B

Revenue—

Net income-5M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out2.01M

Employees6

ListedThu, Oct 28, 2021

Free float1.28M

Float %0.0%

Short interest48.92K

Days to cover1.3d

Short volume48.5%

Squeeze score20 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$1.83 · 1 est

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank7.4 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.92

Support3.68

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in QNRX

All disclosures →

No recent disclosed trades by Congress in QNRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in QNRX

No recent insider (Form 4) filings in QNRX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in QNRX · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.